Clinical Utility of Anti-Glycan Antibodies in Pediatric Crohnʼs Disease in Comparison with An Adult Cohort-Reference-Cited by-同舟云学术

Clinical Utility of Anti-Glycan Antibodies in Pediatric Crohnʼs Disease in Comparison with An Adult Cohort

Published:2012-07 Issue:7 Volume:18 Page:1221-1231
ISSN:1078-0998
Container-title:Inflammatory Bowel Diseases
language:en
Short-container-title:Inflammatory Bowel Diseases

Author:

Rieder Florian,Hahn Philipp,Finsterhoelzl Lydia,Schleder Stephan,Wolf Alexandra,Dirmeier Andrea,Lopez Rocio,Shen Bo,Rogler Gerhard,Klebl Frank,Lang Thomas

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,Immunology and Allergy

Reference31 articles.

1. Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease

2. Serologic Testing with ANCA, ASCA, and Anti-OmpC in Children and Young Adults with Crohn's Disease and Ulcerative Colitis: Diagnostic Value and Correlation with Disease Phenotype

3. Long-term follow-up of patients with Crohn's disease

4. EPIDEMIOLOGY AND THE NATURAL COURSE OF INFLAMMATORY BOWEL DISEASE

5. Association of antibody responses to microbial antigens and complications of small bowel Crohn’s disease

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and Diagnostic Value of Inflammatory Bowel Diseases' Serological Markers in Children (Literature Review);Pediatric pharmacology;2023-08-22

2. Gastrointestinal disease in children with autism spectrum disorders: Etiology or consequence?;World Journal of Psychiatry;2021-09-19

3. Anti-Saccharomyces cerevisiae Antibody in Pediatric Crohn's Disease Patients without Mucosal Healing Is a Useful Marker of Mucosal Damage;Gut and Liver;2021-09-15

4. Prognostic tools for identification of high risk in people with Crohn’s disease: systematic review and cost-effectiveness study;Health Technology Assessment;2021-03

5. Predicting Outcomes in Pediatric Crohn’s Disease for Management Optimization: Systematic Review and Consensus Statements From the Pediatric Inflammatory Bowel Disease–Ahead Program;Gastroenterology;2021-01